OCUL

Ocular Therapeutix Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth↓ 1/10
  • Value↓ 0/10
Ocular Therapeutix sales and earnings growth
OCUL Growth
Low
  • Revenue Y/Y↓ -18.47%
  • EPS Y/Y↓ -16.39%
  • FCF Y/Y↓ -59.43%
Ocular Therapeutix gross and profit margin trends
OCUL Profitability
Low
  • Gross margin ↑ 87.30%
  • EPS margin↓ -511.90%
  • ROIC 5Y↓ -153.29%
Ocular Therapeutix net debt vs free cash flow
OCUL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -21.5

Ocular Therapeutix stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗